Lung Cancer

Lung Cancer Survival May Be Predicted by BMI and Age

Lung Cancer Survival May Be Predicted by BMI and Age

By

Younger age and higher body mass index may be positive predictors of progression-free survival in patients with squamous cell carcinoma of the lung.

Small Cell Lung Cancer: Barriers to Chemotherapy, Radiation

Small Cell Lung Cancer: Barriers to Chemotherapy, Radiation

Lack of insurance correlated with a reduced likelihood of chemotherapy and radiation therapy for small cell lung cancer.

Lack of Communication Regarding Malignancy Risk in Indeterminate Pulmonary Nodules

Lack of Communication Regarding Malignancy Risk in Indeterminate Pulmonary Nodules

By

Qualitative risk statements of malignancy for indeterminate pulmonary nodules are imprecise, highly variable, and should be replaced by a standard scale.

Current Cancer Death Rates in the United States

Current Cancer Death Rates in the United States

The cancer death rate declined by 1.5% annually from 2006 to 2015 in the United States.

Lung Cancer Screening by CT Scan: Risk-Based vs USPSTF Criteria

Lung Cancer Screening by CT Scan: Risk-Based vs USPSTF Criteria

Lung cancer screening based on USPSTF criteria decreased from 2010 to 2015 while risk-targeted screening is associated with modest gains in terms of early lung cancer mortality per person screened.

Measuring Immuno-Oncology Agents Against Cancer Care Framework

Measuring Immuno-Oncology Agents Against Cancer Care Framework

Few modern, US FDA-approved immuno-oncology agents have durable survival and response rates that are deemed significant by the ASCO value framework.

Treatment Disparities in Elderly Patients With Non-Small Cell Lung Cancer

Treatment Disparities in Elderly Patients With Non-Small Cell Lung Cancer

Many octogenarians and nonagenarians with non-small cell lung cancer do not receive cancer-directed care.

Thromboembolic Event Risk With Cisplatin vs Carboplatin in Lung Cancer

Thromboembolic Event Risk With Cisplatin vs Carboplatin in Lung Cancer

By

Platinum-based chemotherapy agents for lung cancer may increase the risk for thromboembolism.

Chemotherapy Followed by Radiotherapy Improves Survival in NSCLC

Chemotherapy Followed by Radiotherapy Improves Survival in NSCLC

By

Adjuvant chemotherapy administered prior to, rather than concurrently with, radiotherapy improves survival outcomes among patients with NSCLC.

Lung Cancer Risk Reduced With Smoke-Free Ordinances

Lung Cancer Risk Reduced With Smoke-Free Ordinances

By

Few cases of lung cancer suspected in counties with smoke-free ordinances.

Cancer Survival Varies by Type of Health Insurance

Cancer Survival Varies by Type of Health Insurance

Improvements in cancer survival were limited to patients with private insurance, from 1997-2014.

Lung Cancer Has Highest Number of Preventable Cases, Deaths

Lung Cancer Has Highest Number of Preventable Cases, Deaths

An estimated 42.0% of all incident cancers and 45.1% of cancer deaths in the United States are attributed to potentially modifiable risk factors.

Lobectomy vs Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer

Lobectomy vs Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer

Survival is better with lobectomy than SBRT in patients with NSCLC.

Traits for High-Value Oncology Practices Identified

Traits for High-Value Oncology Practices Identified

Three of 13 attributes identified had the highest potential for reduced spending without compromising care.

Cancer-Related Fatigue May Benefit From Acupuncture

Cancer-Related Fatigue May Benefit From Acupuncture

By

More than 50% of patients report experiencing cancer-related fatigue throughout the disease process.

Liquid Biopsy May Be a Noninvasive Measure for Treatment Response in NSCLC

Liquid Biopsy May Be a Noninvasive Measure for Treatment Response in NSCLC

By

Patients with PD-L1-positive malignancies have shown higher response rates to immune checkpoint inhibition and consequently prolonged progression-free/overall survival compared with others.

Osimertinib May Improve Outcomes in <i>EGFR</i> Mutation-Postive NSCLC

Osimertinib May Improve Outcomes in EGFR Mutation-Postive NSCLC

Treatment with osimertinib is associated with longer progression-free survival in patients with previously untreated EGFR mutation-positive advanced non-small-cell lung cancer.

Non-Small Cell Lung Cancer: Trends in Stage I Treatment

Non-Small Cell Lung Cancer: Trends in Stage I Treatment

Between 2000 and 2010, researchers identified a decline in the number of patients with stage I NSCLC who remained untreated.

Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel for Long-Term Efficacy

Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel for Long-Term Efficacy

By

Results of two phase 3 studies found that nivolumab provided superior overall survival vs docetaxel in people with non-small cell lung cancer.

Small Cell Lung Cancer Survival With Anticoagulant Therapy

Small Cell Lung Cancer Survival With Anticoagulant Therapy

By

Trial results provided strong evidence against the use of anticoagulant low molecular weight heparin in SCLC.

Anti-Inflammatory Therapy With Canakinumab May Reduce Lung Cancer Rates

Anti-Inflammatory Therapy With Canakinumab May Reduce Lung Cancer Rates

By

Patients with lung cancer and atherosclerosis diagnosis may benefit from anti-inflammatory therapy with canakinumab.

Quality of Life Benefits of Yoga in Non-Small Cell Lung Cancer

Quality of Life Benefits of Yoga in Non-Small Cell Lung Cancer

By

Patients with NSCLC experienced improvements in both function and quality of life with yoga therapy.

Potential Delays in Non-Small Cell Lung Cancer Therapy

Potential Delays in Non-Small Cell Lung Cancer Therapy

By

Study results stress the importance of a multiethnic support system for patients needing to overcome communication barriers.

New "Pan-Can" Model More Accurately Predicts Lung Cancer Risk

New "Pan-Can" Model More Accurately Predicts Lung Cancer Risk

By

PanCan study effectively identified patients who eventually developed early-stage lung cancer, compared to other predictive models.

Updated Lung Cancer Screening Guidelines Released at CHEST

Updated Lung Cancer Screening Guidelines Released at CHEST

By

The ACCP just released new lung cancer screening guidelines.

Lung Cancer Screening Endorsed by Pulmonary and Primary Care Providers

Lung Cancer Screening Endorsed by Pulmonary and Primary Care Providers

Researchers surveyed knowledge, beliefs, attitudes, barriers, and facilitators related to screening patients for lung cancer.

Small-cell Lung Cancer Benefits From Maintenance Therapy With Pazopanib

Small-cell Lung Cancer Benefits From Maintenance Therapy With Pazopanib

By

Pazopanib improves progression-free survival in patients with small-cell lung cancer.

Gefitinib Treatment Should Be Avoided Prior to Chemotherapy in Non-small Cell Lung Cancer

Gefitinib Treatment Should Be Avoided Prior to Chemotherapy in Non-small Cell Lung Cancer

By

First generation EGFR tyrosine kinase inhibitors should be used in combination with chemotherapy if a patient has progressive EGFR mutation-positive non-small cell lung cancer.

Dacomitinib vs Gefitinib for Progression-Free Survival in Non-small Cell Lung Cancer

Dacomitinib vs Gefitinib for Progression-Free Survival in Non-small Cell Lung Cancer

By

Dacomitinib improved progression-free survival in patients with non-small cell lung cancer.

Case Report: Small Cell Lung Cancer Case With Tumor Lysis Syndrome

Case Report: Small Cell Lung Cancer Case With Tumor Lysis Syndrome

Tumor lysis syndrome can occur even in the absence of chemotherapy, and clinicians should remain suspicious when patients demonstrate laboratory abnormalities.

Sign Up for Free e-newsletters